Iris Ventures has acquired a minority stake in Krème, a French pharmacy skincare brand specializing in ultra-sensitive skin formulations. The investment underscores growing momentum around microbiome-focused beauty, where probiotic technology addresses skin barrier integrity rather than masking surface concerns.
Krème's clinical approach leverages probiotics to protect and rebalance the skin's microbiome, positioning the brand within the precision skincare category that has gained traction among dermatologists and ingredient-conscious consumers. The French pharmacy aesthetic carries inherent credibility. Heritage brands like La Roche-Posay and CeraVe have built empires on this clinical-meets-accessible positioning, and Krème enters that terrain with a differentiated angle.
Iris Ventures' backing signals investor appetite for niche skincare solving specific skin conditions rather than chasing viral trends. The venture capital firm has previously backed beauty brands targeting underserved demographics and conditions, reflecting a broader shift away from one-size-fits-all beauty marketing.
Ultra-sensitive skin remains an underexploited category despite its size. Many consumers with compromised barriers gravitate toward established French pharmacy players, but opportunities exist for brands with stronger clinical stories and modern positioning. Krème's probiotic focus taps into microbiome science, a category that gained legitimacy after years of wellness industry hype finally met substantiated research.
The organic certification adds another layer of appeal. Clean beauty consumers increasingly reject synthetic preservatives, and probiotics offer a natural preservation pathway alongside skin benefits. For Iris, the investment hedges against the maturation of larger clean beauty markets by backing a brand with both clinical depth and clean credentials.
This deal reflects consolidation patterns in premium skincare. While mega-acquirers like Estée Lauder and LVMH command headlines, venture capital remains active in identifying emerging brands